Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

The non-apoptotic tumor suppressor mechanisms of p53 in metabolism and senescence

EF 2008-09

Résumé
Cancer is a leading cause of premature death in Canada, with an estimated 159900 new cases of cancer and 72700 deaths in 2007. It is therefore imperative to discover and develop novel drug targets to treat cancer. The p53 protein plays a key role in suppressing cancer, since p53 is mutated in almost all cancers and it can inhibit tumor proliferation and eliminate cancer cells. The major goals of my work are to understand how p53 functions to prevent cancer progression, and how the protective role of p53 is lost to allow tumor to grow. Previous studies have shown that p53 is able to promote cell death to inhibit cancer, however, recently a new target of p53, named TIGAR, was identified that regulates metabolism. The p53 gene has also been indicated to promote cellular aging (senescence) to prevent cancer progression, however, the exact mechanism remains elusive. In this study we will investigate how this new non-cell death activity of p53 contribute to cancer suppression, specifically, how p53 regulates cellular aging through the control of energy metabolism by TIGAR. We will use specific gene targeting techniques in cells and in mouse models of cancer to investigate this novel role of p53. With this information, we may be able to design novel cancer therapeutic strategies based on reinstating p53 functions in tumor cells.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
173718
Name
Cheung Chi-Ching E
Country
United Kingdom
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The non-apoptotic tumor suppressor mechanisms of p53 in metabolism and senescence
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Aging; Cancer; Cancer Metabolism; Glycolysis; Mitochondria; Molecular Biology; Mouse Models Of Cancer; P53; Senescence; Tumor Suppressor
Abstract
Cancer is a leading cause of premature death in Canada, with an estimated 159900 new cases of cancer and 72700 deaths in 2007. It is therefore imperative to discover and develop novel drug targets to treat cancer. The p53 protein plays a key role in suppressing cancer, since p53 is mutated in almost all cancers and it can inhibit tumor proliferation and eliminate cancer cells. The major goals of my work are to understand how p53 functions to prevent cancer progression, and how the protective role of p53 is lost to allow tumor to grow. Previous studies have shown that p53 is able to promote cell death to inhibit cancer, however, recently a new target of p53, named TIGAR, was identified that regulates metabolism. The p53 gene has also been indicated to promote cellular aging (senescence) to prevent cancer progression, however, the exact mechanism remains elusive. In this study we will investigate how this new non-cell death activity of p53 contribute to cancer suppression, specifically, how p53 regulates cellular aging through the control of energy metabolism by TIGAR. We will use specific gene targeting techniques in cells and in mouse models of cancer to investigate this novel role of p53. With this information, we may be able to design novel cancer therapeutic strategies based on reinstating p53 functions in tumor cells.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cheung, Chi-Ching E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~